Literature DB >> 3141187

Platelet viability (aggregation, migration, recovery) after radiolabelling from hypercholesterolemics using various tracers (oxine, oxine-sulphate, tropolone, MPO).

H Sinzinger1, J Flores, K Widhalm, S Granegger.   

Abstract

Earlier results indicated a diminished labelling efficiency and recovery negatively linked to actual cholesterol and lipoprotein values in hyperlipoproteinemics. This study was designed to examine whether other alternative tracers exhibit similar results and to study the influence on platelet viability in the presence or absence of PGI2. We demonstrate that no substantial difference occurs between the four tracers concerning labelling efficiency and recovery in normo- and hypercholesterolemics. Cholesterol severely affects the labelling parameters for all the tracers to a comparable extent. The absolute platelet function varies considerably, however, the percent changes in normo- and hypercholesterolemics seen before and after the labelling procedure do not differ significantly. PGI2 improves recovery in general, however, without affecting labelling efficiency or in vitro viability testing. As prolonged incubation further increases labelling efficiency, the presence and extent of hyperlipoproteinemia should be known in order to avoid poor labeling and viability and subsequently poor clinical results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141187     DOI: 10.1007/bf00254384

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Increased low-density lipoproteins (LDL) negatively affect human platelet labelling.

Authors:  S Granegger; J Flores; K Widhalm; H Sinzinger
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1988

2.  Clinical value of platelet migration test in patients with peripheral vascular disease.

Authors:  J Kaliman; H Sinzinger; G Joskowicz
Journal:  Vasa       Date:  1983       Impact factor: 1.961

3.  An improved method for washing of human platelets with prostacyclin.

Authors:  M Radomski; S Moncada
Journal:  Thromb Res       Date:  1983-05-15       Impact factor: 3.944

4.  Influence of incubation time and temperature on indium-111-oxide uptake by human platelets.

Authors:  H Sinzinger; P Angelberger; H Kolbe
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

5.  Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sites.

Authors:  H Sinzinger; P Fitscha; J Kaliman
Journal:  Prostaglandins       Date:  1987-06

6.  A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials.

Authors:  H Sinzinger; H Kolbe; E Strobl-Jäger; R Höfer
Journal:  Eur J Nucl Med       Date:  1984

7.  [Thrombocyte migration test--method, value and reproducibility].

Authors:  H Sinzinger; J Kaliman; G Joskowicz
Journal:  Wien Klin Wochenschr       Date:  1983-11-25       Impact factor: 1.704

8.  Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.

Authors:  M Boberg; B Vessby; L B Croon
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

9.  Platelet function and platelet lipid composition in the dyslipoproteinemias.

Authors:  K M Shastri; A C Carvalho; R S Lees
Journal:  J Lipid Res       Date:  1980-05       Impact factor: 5.922

10.  Platelet labeling with in-111 oxine: benefit of prostacyclin (PgI2)--addition for preparation and injection.

Authors:  H Sinzinger; P Angelberger; R Höfer
Journal:  J Nucl Med       Date:  1981-03       Impact factor: 10.057

View more
  2 in total

1.  Functional alterations of human platelets following indium-111 labelling using different incubation media and labelling agents.

Authors:  Y Isaka; K Kimura; M Matsumoto; T Kamada; M Imaizumi
Journal:  Eur J Nucl Med       Date:  1991

2.  Platelet function in the postprandial period.

Authors:  Helmut Sinzinger; Robert Berent
Journal:  Thromb J       Date:  2012-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.